Sarah Bock is a partner in Goodwin’s ERISA & Executive Compensation Practice. Ms. Bock advises both private and public companies, with a focus on clients in the life sciences, technology and private equity sectors.

Areas of Practice
Domaines D’Expertise





Ms. Bock advises clients on the design, drafting and administration of equity-based compensation programs, employment, severance, change in control and deferred compensation arrangements, including associated tax (including Section 409A), accounting and securities law implications. She also assists public companies with corporate compensation disclosure for proxy filings and other applicable securities filings. Ms. Bock also plays an active role in corporate transactions, representing both buyers and sellers in connection with employee benefits and compensation-related aspects of transactions, including pre-signing negotiations, executive and equity compensation (including Section 280G – the golden parachute rules) and in post-closing employee integration matters.

Representative Matters



Public Offerings
  • Dynatrace in its $620 million initial public offering
  • Phreesia in its $140.6 million initial public offering
  • Carbon Black in its $152 million initial public offering

  • Neon Therapeutics in its $100 million initial public offering

  • resTORbio in its $85 million initial public offering

  • Xeris Pharmaceuticals in its $98 million initial public offering

  • Scholar Rock in its $86 million initial public offering

  • Ra Pharmaceuticals in its $58 million public follow-on offering

  • Allena Pharmaceuticals in its $75 million initial public offering

  • Deciphera Pharmaceuticals in its $127.5 million initial public offering

  • CRISPR Therapeutics AG in its $56 million initial public offering 

  • BeiGene in it its $158 million initial public offering

  • AquaVenture Holdings in its $117 million initial public offering

M&A – Executive Compensation
  • Carbon Black in its $2.1 billion sale to VMWare
  • Qualtrics in its $8 billion sale to SAP
  • SimpliSafe in its sale to Hellman & Friedman

  • 6 River Systems on its $450 million sale to Shopify

  • Semma Therapeutics in its $950 million sale to Vertex

  • Pillpack in its sale to Amazon

  • Aspire Health in its sale to Anthem

  • Sqrrl Data in its sale to Amazon

  • Guidewire in its $275 million acquisition of Cyence

  • Ocera Therapeutics, in its sale to Mallinckrodt for up to $117 million in upfront cash and contingent (CVR) consideration

  • Merchants Bancshares, Inc. in its sale to Community Bank System, Inc.

  • automotiveMastermind in its partial sale to IHS Markit Ltd. for $392 million

  • Agility Fuel Systems in its merger with the CNG Automotive Products Division of Hexagon Composites to form Agility Fuel Solutions

  • Onyx in its $10 billion sale to Amgen

  • Truck Hero, Inc. in connection with its sale to CCMP

  • ANSYS in numerous acquisition transactions

Professional Activities

Ms. Bock is a member of the Boston Bar Association and American Bar Association.

In The News









J.D., 2006
Boston College

(cum laude)

B.A., 2003
Northwestern University

(magna cum laude)



Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique